Liu P, Lin C, Liu Z, Zhu C, Lin Z, Xu D
There was one serious adverse event in the placebo group (traffic accident) that led to discontinuation from the trial after the last dose
You answer basic health history questions and enter your height and weight for a BMI calculation
Abdullah evaluates the clinical picture at transition ensuring the plateau isn't due to addressable hormonal or metabolic factors before attributing it solely to pharmacologic ceiling
Tirzepatide clears the body in approximately 5 days per half-life (about 25 days total clearance), while semaglutide takes approximately 7 days per half-life (about 35 days total clearance)
These participants lost an average of 10.4 kg of fat mass and 6.92 kg of lean mass, meaning approximately 40% of their weight loss came from lean mass